Research Roundup

Debbie Rigby presents the latest research news relevant to pharmacy Aspirin for Primary Prevention of Atherosclerotic Cardiovascular DiseaseEvidence from a total of 11 trials involving more than 118,000 patients highlights the importance of balancing the benefit of ASCVD reduction with the risk of bleeding from low-dose aspirin for primary prevention. This is facilitated by a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacists lack confidence in supplying naloxone
Next DAAs: Taking the right dose?